<DOC>
	<DOCNO>NCT02070159</DOCNO>
	<brief_summary>Although prasugrel , recently available thienopyridine derivative , exhibit rapid potent platelet inhibition , concern low on-treatment platelet reactivity suggest especially East Asian ethnicity . The investigator compare effect lower loading dose prasugrel conventional loading dose clopidogrel prasugrel .</brief_summary>
	<brief_title>Prasugrel With Lower Dose - Loading Dose</brief_title>
	<detailed_description>Although clopidogrel together aspirin backbone anti-platelet therapy coronary artery disease patient , clopidogrel several limitation . It delay onset peak concentration pharmacodynamic inter-patient response variability result high on-treatment platelet reactivity ( HPR ) . Those demerit know associated adverse cardiovascular outcome . Prasugrel effective metabolism pathway clopidogrel exhibit rapid potent platelet inhibition . Recent guideline recommend prasugrel first line antiplatelet agent put precedence clopidogrel patient acute coronary syndrome . However , concern different pharmacodynamic pharmacokinetic response prasugrel East Asian ethnicity . In addition , low load dose prasugrel exhibit potent pharmacodynamic effect clopidogrel 600 mg comparable efficacy compare conventional load dose prasugrel healthy Korean subject . The investigator compare antiplatelet effect lower loading dose prasugrel 30 mg conventional loading dose clopidogrel 600 mg prasugrel 60 mg Korean coronary artery disease patient undergo elective coronary angiography .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>Patients 18 80 year Stable unstable angina Planned undergo elective coronary angiography Previous history transient ischemic attack stroke Intracranial neoplasm Uncontrolled malignant disease History antiplatelet anticoagulation treatment within 1 month Contraindication study drug Bleeding diathesis Hemoglobin &lt; 10 g/dl Platelet count &lt; 100,000/mm3 Significant renal insufficiency ( glomerular filtration rate &lt; 60 mL/min/1.73 m2 ) Significant hepatic impairment ( Serum liver enzyme bilirubin &gt; 3 time normal limit ) Body weight &lt; 50 kg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>prasugrel</keyword>
	<keyword>platelet function test</keyword>
</DOC>